Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

Study Overview
=================
Brief Summary
-----------------
The purpose of the protocol is to achieve an in-depth understanding of the current satisfaction status of somatostatin analogue (SSA) treatment for acromegaly through patient and physician surveys.

Official Title
-----------------
Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

Conditions
-----------------
Acromegaly

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: For Patients: Age 18 years or older Diagnosed with acromegaly Receiving current SSA injections for acromegaly treatment for at least 3 months Signed electronic Informed Consent Form (eICF) For Physicians: Licensed endocrinologists or neurosurgeons Having prescribed SSAs for at least five patients with acromegaly in the past 6 months Signed eICF Exclusion Criteria: Patients will not be included in the survey if they meet any of the following criteria: Patients who are not able to successfully complete the questionnaire independently Pregnant patients

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patient cohort<br> | |
| Physician cohort<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Overall patient satisfaction with SSA treatment. | To be assessed by four levels of satisfaction including very satisfied, satisfied, dissatisfied, and very dissatisfied | During the whole study period (approximately 3 months). | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient satisfaction with symptom control of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Patient satisfaction with frequency of administration of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Patient satisfaction with mode of administration of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Patient satisfaction with convenience of administration of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Patient satisfaction with injection site reactions of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Patient satisfaction with adverse reactions to SSA treatment |  | During the whole study period (approximately 3 months). | 
| Physician overall satisfaction with SSA treatment. | The satisfaction rate is calculated as the proportion of physicians who reported to be satisfied or very satisfied with the prescribed SSA treatment. | During the whole study period (approximately 3 months). | 
| Physician satisfaction with symptom control of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Physician satisfaction with frequency of administration of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Physician satisfaction with mode of administration of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Physician satisfaction with convenience of administration of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Physician satisfaction with injection site reactions of SSA treatment |  | During the whole study period (approximately 3 months). | 
| Physician satisfaction with adverse reactions to SSA treatment |  | During the whole study period (approximately 3 months). | 
| Aspects of patient concern before initiating SSA treatment | The magnitude of concern will be assessed by four levels including not concerned, slightly concerned, concerned, and very concerned. | During the whole study period (approximately 3 months). | 
| Aspects of physician concern before prescribing SSA treatment | The magnitude of concern will be assessed by four levels including not concerned, slightly concerned, concerned, and very concerned. | During the whole study period (approximately 3 months). | 
| Overall patient satisfaction with SSA treatment: satisfied versus dissatisfied with their SSA treatment. | The patient satisfaction will be categorized as binary variables including satisfied (very satisfied and satisfied) versus dissatisfied (dissatisfied and very dissatisfied). | During the whole study period (approximately 3 months). |